Patents by Inventor Naomasa Yamamoto

Naomasa Yamamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MARKER FOR ACUTE CORONARY SYNDROME, AND USE THEREOF
    Publication number: 20150219644
    Abstract: The present invention provides a method of testing plasma and/or serum of a test subject for determining the pathology or onset risk of acute coronary syndrome, including (1) a step of measuring a soluble amyloid ? precursor protein (sAPP) 770 level of plasma and/or serum of a test subject; and (2) a step of relating the plasma and/or serum sAPP770 level(s) measured in (1) to the pathology or onset risk of acute coronary syndrome.
    Type: Application
    Filed: June 6, 2013
    Publication date: August 6, 2015
    Applicant: RIKEN
    Inventors: Shinobu Kitazume, Akiomi Yoshihisa, Takayoshi Yamaki, Yasuchika Takeishi, Yasuhiro Hashimoto, Naoyuki Taniguchi, Rie Imamaki, Naomasa Yamamoto, Tsutomu Seito
  • Fusion partner cells
    Patent number: 8173425
    Abstract: Fusion partner cells that enable production of heterohybridomas even from cells of species other than mouse were produced by fusing myeloma cells derived from a first animal species with leukemia cells derived from a second animal species, which have an extra S phase in the cell cycle and have the property of diploidizing. Stable production of substances can be achieved by producing heterohybridomas through cell fusion between the fusion partner cells and substance-producing cells of an animal other than mouse.
    Type: Grant
    Filed: April 13, 2007
    Date of Patent: May 8, 2012
    Assignees: N{dot over (a)}omasa Yamamoto, Medical & Biological Laboratories Co., Ltd.
    Inventors: Naomasa Yamamoto, Mizuho Kaneda
  • BLOOD OXIDATION INHIBITING APPARATUS
    Publication number: 20110307022
    Abstract: [Problem to be Solved] A compact and light weight, and inexpensive blood oxidation inhibiting apparatus which uses fluid activating bodies, being capable of inhibiting oxidative stress on the blood of a human body is provided.
    Type: Application
    Filed: June 10, 2011
    Publication date: December 15, 2011
    Inventors: Katsuyuki Kumano, Naomasa Yamamoto, Norifumi Yonehara, Yuichi Koike
  • FUSION PARTNER CELLS
    Publication number: 20100028946
    Abstract: Fusion partner cells that enable production of heterohybridomas even from cells of species other than mouse were produced by fusing myeloma cells derived from a first animal species with leukemia cells derived from a second animal species, which have an extra S phase in the cell cycle and have the property of diploidizing. Stable production of substances can be achieved by producing heterohybridomas through cell fusion between the fusion partner cells and substance-producing cells of an animal other than mouse.
    Type: Application
    Filed: April 13, 2007
    Publication date: February 4, 2010
    Applicants: Medical & Biological Laboratories Co., Ltd.
    Inventors: Naomasa Yamamoto, Mizuho Kaneda
  • Platelet membrane glycoprotein VI (GPVI) DNA and protein sequences, and uses thereof
    Patent number: 6998469
    Abstract: The present invention comprises a method of purifying GPVI, GPVI peptides, cDNA and protein sequence, and methods for using GPVI and antibodies directed against GPVI.
    Type: Grant
    Filed: May 29, 2003
    Date of Patent: February 14, 2006
    Assignee: Otsuka America Pharmaceutical, Inc.
    Inventors: Narendra Nath Tandon, Bing Sun, Takashi Nakamura, Naomasa Yamamoto
  • Platelet membrane glycoprotein VI (GPVI) DNA and protein sequences, and uses thereof
    Publication number: 20040152628
    Abstract: The present invention comprises a method of purifying GPVI, GPVI peptides, cDNA and protein sequence, and methods for using GPVI and antibodies directed against GPVI.
    Type: Application
    Filed: May 29, 2003
    Publication date: August 5, 2004
    Applicant: Otsuka America Pharmaceutical Inc.
    Inventors: Narendra Nath Tandon, Bing Sun, Takashi Nakamura, Naomasa Yamamoto
  • Platelet membrane glycoprotein VI (GPVI) DNA and protein sequences, and uses thereof
    Publication number: 20030186885
    Abstract: The present invention comprises a method of purifying GPVI, GPVI peptides, cDNA and protein sequence, and methods for using GPVI and antibodies directed against GPVI.
    Type: Application
    Filed: May 29, 2003
    Publication date: October 2, 2003
    Applicant: Otsuka America Pharmaceutical Inc.
    Inventors: Narendra Nath Tandon, Bing Sun, Takashi Nakamura, Naomasa Yamamoto